TSX.V: LXG | OTCQB: LXXGF
  • Technology
        • MiQLab
        • How It Works
        • What is PCR testing
        • Publications
  • Products
        • MiQLab for Human Clinical Diagnostics
        • MiQLab for Veterinary Diagnostics
          • MiQLab Bacterial and AMR Test
        • MiQLab for Food Safety Testing
        • MiQLab for Open-Access Testing
        • Request Information
  • Company
        • About
          • Leadership
          • Board of Directors
          • Scientific Advisory Board
        • Contact
          • Request Product Information
          • Subscribe to Investor Updates
        • Careers
  • News
        • News Releases
        • Media Coverage
        • Events
  • Investors
        • Investor Overview
          • Markets
          • Stock Information
          • Share Structure
          • Financials
          • Analyst Coverage
          • Presentations
        • News
          • Media Coverage
          • Events
        • Subscribe To Updates
  • Resources
        • Product info
        • Videos
        • Presentations
        • All Resources
  • Technology
        • MiQLab
        • How It Works
        • Publications
        • What is PCR testing
  • Products
        • MiQLab for Human Clinical Diagnostics
        • MiQLab for Veterinary Diagnostics
        • MiQLab Bacterial and AMR Test
        • MiQLab for Food Safety Testing
        • MiQLab for Open-Access Testing
        • Request Information
  • Company
        • About
        • Leadership
        • Board of Directors
        • Scientific Advisory Board
        • Contact
        • Request Product Information
        • Subscribe to Investor Updates
        • Careers
  • News
        • News Releases
        • Media Coverage
        • Events
  • Investors
        • Investor Overview
        • Markets
        • Stock Information
        • Share Structure
        • Financials
        • Presentations
        • News
        • Media Coverage
        • Events
        • Subscribe To Updates
  • Resources
        • All Resources
        • Videos
        • Presentations
        • Product info
  • News
  • Investors
  • Contact
  • Privacy
  • Terms
  • Site Map
MiQLab™ for Human Clinical Diagnostics

Rapid Molecular Testing Made Easy

This product is currently not cleared by the FDA and cannot be used for human clinical diagnostics. LexaGene is currently pursuing FDA Emergency Use Authorization for SARS-CoV-2 (COVID-19) testing.

MiQLab for Human Clinical Diagnostics

 

Obtain clinical insight in less time when critical answers matter. Rely on accurate molecular testing to improve the diagnostic and treatment process for better managed patient care.

 
 

Overview


LexaGene’s MiQLab rapid and fully automated pathogen detection system is intended to accelerate diagnostic testing to enable evidence-based treatment decisions.

MiQLab System

Test Menu

Related

This product is currently not cleared by the FDA and cannot be used for human clinical diagnostics. LexaGene is currently pursuing FDA Emergency Use Authorization for SARS-CoV-2 (COVID-19) testing.

Intended for rapid and automated pathogen detection for better patient outcomes.

Upon obtaining FDA clearance, MiQLab will allow health care professionals to rapidly identify infectious disease with actionable insights for better patient triage and care.

MiQLab system photo front viewMiQLab system angled to the leftMiQLab system angled to the right

The MiQLab system uses real-time polymerase chain reaction (qPCR) to simultaneously screen for up to 27 targets with high sensitivity and specificity and return results in ~1 hour.

The system is designed to expand with additional tests to meet the most urgent clinical needs.

Test under development. LexaGene is not making any express or implied claims that its product has the ability to identify, eliminate, cure or contain COVID-19 (SARS Coronavirus-2) at this time. This product is currently not cleared by the FDA and cannot be used for human clinical diagnostics. LexaGene is pursuing FDA Emergency Use Authorization for SARS-CoV-2 (COVID-19) testing.

MiQLab™ SARS-CoV-2 Test

Icon for human clinical diagnostics

LexaGene is currently developing a MiQLab™ SARS-CoV-2 test.

Click request for information to learn more about MiQLab™ for Clinical Diagnostics and MiQLab SARs-CoV-2 Test. These products are currently not FDA-cleared.

 

Request Product Information

Features and Benefits

Icon denoting multiplexing

Multiplex Detection

Simultaneously detect up to 27 pathogens and other molecular markers by real-time PCR.

Icon for touch screen

Intuitive Navigation

Integrated barcode reader and convenient touchscreen simplifies data entry and results viewing.

Icon of sample cartridge

Easy Workflow

Simply add patient sample to cartridge and load it onto MiQLab with <1 min hands-on time

Icon denoting speed

Rapid Turnaround

Sample-to-answer in about 1 hr vs. waiting days for traditional culture and sensitivity test results

Icon denoting test results

Automated Reporting

Wireless transfer PDF report to mobile devices, computers, and record-keeping system.

Icon for open-access

Expandable Test Menu

Designed to support growing menu of MiQLab rapid molecular tests.

MiQLab Sample-to-Answer Workflow

The MiQLab is easy to operate with a simple sample-to-answer workflow.

MiQLab Technology

This all-in-one automated system seamlessly integrates nucleic acid extraction and purification, target amplification, detection, and reporting.

REQUEST PRODUCT INFORMATION
Tweets by lexa_gene

Subscribe for updates

By clicking Sign Up, you consent to receive electronic messages from LexaGene, including company news, updates, and other notifications.

  • News
  • Investors
  • Contact
  • Privacy
  • Terms
  • Site Map

©2021 LexaGene. All rights reserved

500 Cummings Ctr., Suite 4550 Beverly, MA 01915 USA | info@lexagene.com | 800.215.1824